STOCKWATCH
·
Pharmaceuticals
Quarterly Result22 Jul 2025, 02:00 pm

Blue Jet Healthcare Reports Q1 FY26 Results: Revenue Surges 117.8% YoY, EBITDA Margin Climbs to 34.1%

AI Summary

Blue Jet Healthcare Limited (BLUEJET) has reported financial results for the quarter ended June 30, 2025. The company's revenue from operations stood at Rs. 3,548 mn, a growth of 117.8% YoY. EBITDA came in at Rs. 1,210 million, up 173.3% YoY. The EBITDA margin for the quarter was 34.1%, up 693 bps YoY. The growth was primarily driven by the ramp up in Pl & API product categories. The company remains confident in its growth strategy, driven by capacity expansions, enhanced R&D capabilities, and a robust pipeline of high-value products.

Key Highlights

  • Revenue from operations for Q1 FY26 stood at Rs. 3,548 mn, a growth of 117.8% YoY.
  • EBITDA for the quarter came at Rs. 1,210 mn, up 173.3% YoY.
  • EBITDA margin for the quarter was 34.1%, up 693 bps YoY.
  • PAT for the quarter was at Rs. 912 mn, up 141.3% YoY.
  • The growth was primarily driven by the ramp up in Pl & API product categories.
BLUEJET
Pharmaceuticals
Blue Jet Healthcare Ltd

Price Impact